Tekcapital commercialises university-developed technology and has built a portfolio of four publicly-listed and privately-held companies with the potential to improve millions of people’s lives. Tekcapital shares trade at a substantial discount to their portfolio’s NAV and our fair value indicative target of 21.4p represents 104% upside from the current share price of 10.375p.

Tekcapital is an intellectual property group which is underappreciated by the AIM market upon which it resides. There is a growing problem across the English-speaking western world, in that the US and UK boast some of the best research universities in the world but struggles to monetise the technological developments cultivated at these world class institutions. Tekcapital’s mission is to commercialise such technologies and create shareholder value.

Tekcapital is set up for long-term growth, with all four key portfolio companies achieving significant milestones over the past 12 months. However, due to unrealised reductions in the value of Lucyd and Belluscura, Tekcapital’s profitability and net assets were significantly impacted in 2022 full-year results.

Download your research report now for instant access. Exclusively aimed at UK resident persons who are required to self-certify as either a Sophisticated Investor or High Net Worth Individuals.

Download Report

Please read the High Net Worth Individual Statement or Sophisticated Investor Statement before downloading this guide.